Cardiac amyloidosis used to be a disease with no treatment and poor outcomes. Now we have new treatment options, new ways to make the diagnosis, and much improved outcomes. Unfortunately, this disease is still very under-diagnosed, often until patients are in the late stages of the disease. Dr. Parker shares a brief update on how cardiac amyloidosis develops, and how it's diagnosed and treated in the modern era.